🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 5

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 5 of 9
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Dec 7, 2025 at 2:03 PM#21
andrew_nyc said:
The useful move here is to separate what is established from what is widely repeated.

Adding the part of the answer the thread has not reached. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

31 4NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 28 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Dec 14, 2025 at 3:15 PM#22

The figures, for anyone assembling their own picture. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

32 5InsuranceTom, WendyG_ATL, SaraMom3 and 29 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Dec 21, 2025 at 4:23 PM#23

Following on from andrew_nyc — and this may be the naive question:

What did you change at the same time, and can you separate the two now?

Last edited: Dec 21, 2025 at 5:23 PM
33 6lori_vegas, Dr.PulmRoch, maya_sedona and 30 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Dec 28, 2025 at 5:26 PM#24
Dr.PathRoch said:
Say what you would expect to see if you were wrong, before you look.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

34 7Dr.MetabolicMD, RetaRick_CA, JenPlateau and 31 others
Reply Quote Save Share Report
ben_calgary
Member
245
1,123
Oct 2024
Calgary, CA
Jan 4, 2026 at 6:26 PM#25
Dr.PathRoch said:
Say what you would expect to see if you were wrong, before you look.

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

35 8NauseaFreeNow, SteveThurs, B12Beth and 32 others
Reply Quote Save Share Report
1345679

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register